← Back to Clinical Trials
Recruiting NCT06686732

NCT06686732 Multimodal Rehabilitation Approach in Patients of Lateral Epicondylitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06686732
Status Recruiting
Phase
Sponsor Riphah International University
Condition Lateral Epicondylitis
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-05-03
Primary Completion 2024-12-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Multimodal physiotherapyConventional physiotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-05-03 with a primary completion date of 2024-12-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Literature is scarce for high quality evidence regarding multimodal rehabilitation in lateral epicondylitis. By making comparisons with the conventional treatment of patients with lateral epicondylitis, the current study aims to further establish the efficacy of the multimodal rehabilitation protocol through a RCT in order to generalize the results, using dynamometer as an additional tool for pre and post assessments against the outcome measures. Remarks A randomized control trial was conducted at Physical therapy departments of twin cities. The sample size was 40 calculated through G- power tool. The participants were divided into two interventional groups each having 20 participants. The study duration was eight months. Sampling technique applied was non- probability convience sampling. People of age 18-45 years, with localized point tenderness at lateral epicondyle with Mills, Cozen and Maudselys test positive were included in this research. Tools used in this study are Visual Analogue Scale, Dynamometer, Patient Rated Tennis Elbow Questionnaire. Data was collected before and immediately after the application of interventions. Data analyzed through SPSS version 23.

Eligibility Criteria

Inclusion Criteria: * Point tenderness at the lateral epicondyle * Positive Cozen test, Mill\'s test and Maudsely's test * Symptoms duration of minimum 2 months * Consenting to participate in the study Exclusion Criteria: * History of fracture in elbow, wrist or hand * History of surgery in elbow, wrist or hand region * Elbow conditions other than lateral epicondylitis * Cognitive deficits and not giving consent

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 +923324390125

Principal Investigator

Ramsha Tariq, MS*

PRINCIPAL INVESTIGATOR

Riphah International University, Islamabad

Frequently Asked Questions

Who can join the NCT06686732 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06686732 currently recruiting?

Yes, NCT06686732 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06686732 trial being conducted?

This trial is being conducted at Wāh, Pakistan, Islamabad, Pakistan, Rawalpindi, Pakistan.

Who is sponsoring the NCT06686732 clinical trial?

NCT06686732 is sponsored by Riphah International University. The principal investigator is Ramsha Tariq, MS* at Riphah International University, Islamabad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology